Stock Taper
EXCHANGE TRADED FUND

ASD

Defiance Autism Impact ETF
$26.61 ▲ 0.62%
+$0.17 TODAY

FUND FACTS

Manager Defiance
Assets $1.31M
Expense ratio 0.79%
Inception Jun 1, 2026
Asset class Equity
Holdings 22
Volume 450
Avg volume 510

ABOUT THIS FUND

It operates as an exchange-traded investment fund.

PRICE

$26.61 ▲ UP 0.62% (+$0.17)
$26.40$26.50$26.609:35 AM10:02 AM10:29 AM10:56 AM11:23 AM11:50 AM12:17 PM26.61

HOLDINGS

TOP 20 OF 22 · 52.23% OF THE FUND
RANK STOCK WEIGHT SHARES VALUE
02 LLY Eli Lilly and Company 2.89% 32 $38.04K
03 GHC Graham Holdings Company 2.85% 32 $37.43K
04 ABBV AbbVie Inc. 2.85% 138 $37.45K
07 RGEN Repligen Corporation 2.75% 216 $36.12K
10 PFE Pfizer Inc. 2.71% 1.27K $35.67K
11 LRN Stride, Inc. 2.63% 434 $34.55K
12 JNJ Johnson & Johnson 2.63% 134 $34.63K
13 JAZZ Jazz Pharmaceuticals plc 2.60% 148 $34.22K
19 BWAY BrainsWay Ltd. 2.24% 2.53K $29.45K
20 ACAD Acadia Pharmaceuticals Inc. 1.90% 1.27K $24.95K

SECTOR HOLDINGS

TECHNOLOGY IS 1.00% OF THE FUND

BY REGION

UNITED STATES IS 54.14% OF THE FUND
United States 54.14%
Japan 10.84%
Switzerland 5.55%
United Kingdom 5.45%
Israel 5.09%
— Other 3.24%
Sweden 2.85%
Denmark 2.63%
Ireland 2.60%
South Africa 2.60%
Australia 2.59%
France 2.39%